07 Sep 2018 --- Pharmaceutical company Mundipharma has closed an asset purchase agreement with Vital Food Processors Limited, an agricultural science company founded in New Zealand, for the global rights to commercialize Zyactinase – a clinically-proven gastrointestinal consumer health product. Zyactinase is a freeze-dried extract of Kiwifruit (Actinidia deliciosa) that has been developed as a constipation relief product as well as for long-term gut health. It contains a protease complex, fiber, pectin and fructo-oligosaccharides that stimulates increased bowel movements.
